CME Group (NASDAQ: CME) files Form 144 to sell 3,291 shares
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
CME Group reported a Form 144 notice for a proposed sale of issuer-held equity. The filing lists 3,291 total shares identified for sale: 398 Restricted Stock and 2,893 Performance Shares, each dated 03/15/2026. The securities are described as ISSUER-held on NASDAQ.
Positive
- None.
Negative
- None.
FAQ
What does CME's Form 144 disclose?
The filing discloses a proposed sale of 3,291 shares dated 03/15/2026. It breaks down to 398 Restricted Stock and 2,893 Performance Shares, each listed as ISSUER-held for sale on NASDAQ.
Who is the filer on the CME Form 144?
The filer is listed as Morgan Stanley Smith Barney LLC Executive Financial Services with an address at 1 New York Plaza. The filing presents the broker-dealer acting in connection with the Form 144 submission.
What types of securities are included in the sale?
The filing identifies two security types: Restricted Stock (398 shares) and Performance Shares (2,893 shares), both dated 03/15/2026 and designated as ISSUER-held.
When were the securities to be sold dated?
All securities listed in the Form 144 are dated 03/15/2026. The filing entry shows the proposed sale date and categorizes each lot as issuer-held restricted or performance-based awards.
Does the Form 144 state proceeds or sale method?
The excerpt does not state proceeds or describe a specific sale method. It lists security types and share counts but does not provide sale proceeds, pricing, or distribution mechanics in the provided content.